Tops & Flops Stocks
| Security | Change (%) | 1w ▲ | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | -1.380% | -5.702% | -11.523% | 7.500% | -10.788% | -44.516% | - |
| Kezar Life Sciences | - | -5.442% | -6.711% | -74.819% | -20.571% | -84.347% | - |
| iRhythm Technologies Inc | -5.430% | -5.435% | -16.346% | -24.348% | -10.769% | 30.827% | - |
| Cytomx Therapeutics Inc | -4.520% | -5.426% | 5.381% | 6.933% | 24.857% | -74.739% | - |
| Fate Therapeutics Inc. | 2.390% | -5.299% | -27.332% | -22.519% | 1.012% | -94.278% | - |
| Enanta Pharmaceuticals Inc. | -6.780% | -5.172% | -14.729% | -52.586% | 25.000% | -72.906% | -86.458% |
| Cytokinetics Inc. | -0.900% | -5.172% | -14.063% | 57.143% | -28.105% | 180.612% | - |
| Akebia Therapeutics Inc. | 1.520% | -5.094% | -18.807% | 2.708% | -9.386% | -62.071% | - |
| Salarius Pharmaceuticals Inc. | 7.850% | -5.069% | -4.630% | -67.040% | -25.766% | -98.502% | -99.992% |
| Aclaris Therapeutics Inc | -1.250% | -4.881% | -6.242% | -85.955% | 13.842% | -94.012% | - |
| Oramed Pharmaceuticals | 1.300% | -4.633% | -2.708% | -36.603% | 0.189% | -76.018% | -23.438% |
| Trevena Inc. | -3.090% | -4.564% | 1.322% | -67.143% | -43.535% | -98.918% | -98.829% |
| Verastem Inc. | -1.790% | -4.505% | 0.000% | 127.898% | 40.397% | -63.559% | - |
| Rigel Pharmaceutical Inc. | -3.140% | -4.148% | -17.867% | -47.847% | -36.789% | -71.033% | - |
| Ani Pharmaceuticals Inc. | -1.630% | -4.032% | -4.800% | 44.417% | 19.478% | 115.580% | -5.225% |
| Kyowa Hakko Kirin Co. Ltd. | -1.940% | -3.797% | -3.185% | -14.607% | 2.703% | -39.200% | -6.369% |
| XBiotech Inc | -2.560% | -3.797% | -4.403% | 131.707% | 114.689% | -45.324% | -7.045% |
| Harvard Bioscience | - | -3.727% | -19.271% | -38.000% | -35.146% | -46.552% | 47.901% |
| Kala Pharmaceuticals Inc. | - | -3.577% | -4.968% | -59.824% | -9.049% | -97.278% | - |
| Theravance Biopharma | -3.410% | -3.409% | -6.077% | -15.000% | -16.667% | -43.333% | - |
| Surgery Partners Inc | -1.650% | -3.252% | 3.478% | -29.167% | -17.361% | -44.131% | 164.298% |